Activity ID



May 17, 2024

Format Type


CME Credit




CME Provider: Clinical Care Options, LLC

Description of CME Course

The goal of this program is to improve the knowledge and competence of learners to optimize treatment for patients with ADAD.

Register for this Activity

ABMS Member Board Approvals by Type
More Information
Commercial Support?

NOTE: If a Member Board has not deemed this activity for MOC approval as an accredited CME activity, this activity may count toward an ABMS Member Board’s general CME requirement. Please refer directly to your Member Board’s MOC Part II Lifelong Learning and Self-Assessment Program Requirements.

Educational Objectives

• Identify the hypothesized mechanism of disease in ADAD, including neurotransmitter and brain region involvement
• Recognize the mechanisms of action for new and emerging treatment options for ADAD
• Assess the latest clinical evidence for new and emerging options for the treatment of ADAD


Alzheimer's Disease COVID-19


Medical Knowledge

CME Credit Type

AMA PRA Category 1 Credit

Practice Setting

Academic Medicine, Inpatient, Outpatient, Rural, Urban, VA/Military

View All Activities by this CME Provider

The information provided on this page is subject to change. Please refer to the CME Provider’s website to confirm the most current information.